Bank of Montreal’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $58.3K | Hold |
287
| – | – | ﹤0.01% | 3390 |
|
|
2026
Q1 | $54K | Hold |
287
| – | – | ﹤0.01% | 3270 |
|
|
2025
Q4 | $54.3K | Hold |
287
| – | – | ﹤0.01% | 3180 |
|
|
2025
Q3 | $47.5K | Hold |
287
| – | – | ﹤0.01% | 3137 |
|
|
2025
Q2 | $44K | Hold |
287
| – | – | ﹤0.01% | 3164 |
|
|
2025
Q1 | $45.2K | Hold |
287
| – | – | ﹤0.01% | 3090 |
|
|
2024
Q4 | $45K | Hold |
287
| – | – | ﹤0.01% | 3128 |
|
|
2024
Q3 | $50.7K | Hold |
287
| – | – | ﹤0.01% | 3413 |
|
|
2024
Q2 | $49.8K | Hold |
287
| – | – | ﹤0.01% | 3423 |
|
|
2024
Q1 | $48K | Hold |
287
| – | – | ﹤0.01% | 3461 |
|
|
2023
Q4 | $47.8K | Buy |
287
+55
| +24% | +$8.47K | ﹤0.01% | 3577 |
|
|
2023
Q3 | $37.6K | Sell |
232
-35
| -13% | -$5.59K | ﹤0.01% | 3473 |
|
|
2023
Q2 | $43.1K | Sell |
267
-13
| -5% | -$2.08K | ﹤0.01% | 3625 |
|
|
2023
Q1 | $46.1K | Buy |
280
+48
| +21% | +$7.77K | ﹤0.01% | 3387 |
|
|
2022
Q4 | $38.9K | Hold |
232
| – | – | ﹤0.01% | 3591 |
|
|
2022
Q3 | $35 | Sell |
232
-1,406
| -86% | -$213K | ﹤0.01% | 3698 |
|
|
2022
Q2 | $245 | Sell |
1,638
-164
| -9% | -$24.4K | ﹤0.01% | 3134 |
|
|
2022
Q1 | $295K | Buy |
1,802
+462
| +34% | +$74.8K | ﹤0.01% | 3201 |
|
|
2021
Q4 | $256K | Buy |
1,340
+59
| +5% | +$11.4K | ﹤0.01% | 2825 |
|
|
2021
Q3 | $280K | Buy |
1,281
+261
| +26% | +$54.8K | ﹤0.01% | 3170 |
|
|
2021
Q2 | $206K | Buy |
1,020
+457
| +81% | +$85.1K | ﹤0.01% | 3199 |
|
|
2021
Q1 | $99K | Buy |
563
+123
| +28% | +$22.2K | ﹤0.01% | 3396 |
|
|
2020
Q4 | $78K | Buy |
+440
| New | +$72.5K | ﹤0.01% | 3712 |
|
|
2017
Q1 | – | Sell |
-325
| Closed | -$35K | – | 3969 |
|
|
2016
Q4 | $35K | Hold |
325
| – | – | ﹤0.01% | 3222 |
|
|
2016
Q3 | $37K | Hold |
325
| – | – | ﹤0.01% | 3142 |
|
|
2016
Q2 | $33K | Hold |
325
| – | – | ﹤0.01% | 3191 |
|
|
2016
Q1 | $34K | Sell |
325
-120
| -27% | -$12.5K | ﹤0.01% | 3194 |
|
|
2015
Q4 | $56K | Sell |
445
-30
| -6% | -$3.67K | ﹤0.01% | 2999 |
|
|
2015
Q3 | $54K | Hold |
475
| – | – | ﹤0.01% | 2888 |
|
|
2015
Q2 | $64K | Sell |
475
-920
| -66% | -$122K | ﹤0.01% | 2921 |
|
|
2015
Q1 | $181K | Hold |
1,395
| – | – | ﹤0.01% | 2403 |
|
|
2014
Q4 | $160K | Buy |
1,395
+100
| +8% | +$11.3K | ﹤0.01% | 2558 |
|
|
2014
Q3 | $137K | Sell |
1,295
-150
| -10% | -$15.2K | ﹤0.01% | 2694 |
|
|
2014
Q2 | $137K | Sell |
1,445
-1,919
| -57% | -$172K | ﹤0.01% | 2679 |
|
|
2014
Q1 | $305K | Sell |
3,364
-61,433
| -95% | -$5.97M | ﹤0.01% | 2317 |
|
|
2013
Q4 | $5.74M | Buy |
64,797
+1,262
| +2% | +$106K | 0.01% | 796 |
|
|
2013
Q3 | $5.26M | Sell |
63,535
-1,699
| -3% | -$133K | 0.01% | 764 |
|
|
2013
Q2 | $4.47M | Buy |
+65,234
| New | +$4.54M | 0.01% | 766 |
|
Other funds holding BBH
MIM
CCA
BFG
PPWM
IWC
Bank of Montreal's BBH Position: Q2 2026 in Review
Bank of Montreal held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 287 shares worth $58.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3390.
Bank of Montreal first reported a position in BBH in Q2 2013 and has held it in 38 quarters since. The position peaked at $5.74M in Q4 2013. 95 funds tracked by Wall St. Rank hold BBH as of Q2 2026.
- Bank of Montreal held 287 shares of VanEck Biotech ETF worth $58.3K as of Q2 2026.
- Bank of Montreal left its VanEck Biotech ETF share count unchanged in Q2 2026.
- VanEck Biotech ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3390 holding.
- Bank of Montreal first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 38 quarters since.
- Bank of Montreal's VanEck Biotech ETF position peaked at $5.74M in Q4 2013.
- 95 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.